2015-000660-33: A clinical trial to study the efficacy and safety of an investigational medication, beloranib, in treatment of food-related behaviour and weight in obese individuals with Prader-Willi Syndrome by comparison with placebo |
|
|
| | 3 | 25 | Europe | Subcutaneous Beloranib in Suspension, ZGN-440, | Zafgen Inc., Zafgen Inc. | Improvement of Hyperphagia and related behaviors as well as Body Composition/Overweight in Prader-Willi-Syndrome | | | | |